Tuis4516 • TYO
add
Nippon Shinyaku Co Ltd
Vorige sluiting
¥3 258,00
Dagwisseling
¥3 241,00 - ¥3 263,00
Jaarwisseling
¥2 967,00 - ¥4 414,00
Markkapitalisasie
228,25 mjd JPY
Gemiddelde volume
298,21 k
P/V-verhouding
7,16
Dividend-opbrengs
3,82%
Primêre beurs
TYO
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (JPY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 39,55 mjd | 1,06% |
Bedryfskoste | 16,81 mjd | 9,04% |
Netto inkomste | 8,26 mjd | -19,57% |
Netto winsgrens | 20,87 | -20,43% |
Wins per aandeel | — | — |
EBITDA | 11,67 mjd | -6,94% |
Effektiewe belastingkoers | 21,40% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (JPY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 58,28 mjd | 6,99% |
Totale bates | 289,62 mjd | 8,95% |
Totale aanspreeklikheid | 37,79 mjd | -1,50% |
Totale ekwiteit | 251,83 mjd | — |
Uitstaande aandele | 67,38 m | — |
Prys om te bespreek | 0,87 | — |
Opbrengs op bates | 8,79% | — |
Opbrengs op kapitaal | 10,00% | — |
Kontantvloei
Netto kontantverandering
| (JPY) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 8,26 mjd | -19,57% |
Kontant van bedrywe | 6,80 mjd | -2,94% |
Kontant van beleggings | 908,00 m | 113,38% |
Kontant van finansiering | -4,29 mjd | 0,97% |
Netto kontantverandering | 3,04 mjd | 183,84% |
Beskikbare kontantvloei | — | — |
Meer oor
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
Gestig
01 Okt. 1919
Webwerf
Werknemers
2 243
